Current insights into the biology and pathogenesis of Pneumocystis pneumonia
- PMID: 17363968
- DOI: 10.1038/nrmicro1621
Current insights into the biology and pathogenesis of Pneumocystis pneumonia
Abstract
The fungal infection Pneumocystis pneumonia is the most prevalent opportunistic infection in patients with AIDS. Although the analysis of this opportunistic fungal pathogen has been hindered by the inability to isolate it in pure culture, the use of molecular techniques and genomic analysis have brought insights into its complex cell biology. Analysis of the intricate relationship between Pneumocystis and the host lung during infection has revealed that the attachment of Pneumocystis to the alveolar epithelium promotes the transition of the organism from the trophic to the cyst form. It also revealed that Pneumocystis infection elicits the production of inflammatory mediators, culminating in lung injury and impaired gas exchange. Here we discuss these and other recent findings relating to the biology and pathogenesis of this intractable fungus.
Comment in
-
Pneumocystis pneumonia: immunosuppression, Pneumocystis jirovecii...and the third man.Nat Rev Microbiol. 2007 Dec;5(12). doi: 10.1038/nrmicro1621-c1. Nat Rev Microbiol. 2007. PMID: 19507333 No abstract available.
Similar articles
-
Pneumocystis carinii: the art and science of survival in the hostile environment of the alveolar spaces.Semin Respir Infect. 1998 Dec;13(4):348-52. Semin Respir Infect. 1998. PMID: 9872632 Review.
-
Pathogenesis and host response in Pneumocystis carinii pneumonia.Annu Rev Med. 1994;45:261-72. doi: 10.1146/annurev.med.45.1.261. Annu Rev Med. 1994. PMID: 8198382 Review.
-
Trophozoite elimination in a rat model of Pneumocystis carinii pneumonia by clinically achievable plasma deferoxamine concentrations.Antimicrob Agents Chemother. 1996 May;40(5):1298-300. doi: 10.1128/AAC.40.5.1298. Antimicrob Agents Chemother. 1996. PMID: 8723489 Free PMC article.
-
Pathobiology of Pneumocystis pneumonia: life cycle, cell wall and cell signal transduction.FEMS Yeast Res. 2015 Sep;15(6):fov046. doi: 10.1093/femsyr/fov046. Epub 2015 Jun 12. FEMS Yeast Res. 2015. PMID: 26071598 Review.
-
Pneumocystis carinii: an atypical fungal micro-organism.J Med Vet Mycol. 1996 Jul-Aug;34(4):227-39. doi: 10.1080/02681219680000401. J Med Vet Mycol. 1996. PMID: 8873881 Review.
Cited by
-
A critical role for CARD9 in pneumocystis pneumonia host defence.Cell Microbiol. 2020 Oct;22(10):e13235. doi: 10.1111/cmi.13235. Epub 2020 Jul 22. Cell Microbiol. 2020. PMID: 32548948 Free PMC article.
-
Low Titer Pneumocystis jirovecii Infections: More than Just Colonization?J Fungi (Basel). 2016 May 28;2(2):16. doi: 10.3390/jof2020016. J Fungi (Basel). 2016. PMID: 29376933 Free PMC article.
-
Evidence of the Red-Queen Hypothesis from Accelerated Rates of Evolution of Genes Involved in Biotic Interactions in Pneumocystis.Genome Biol Evol. 2018 Jun 1;10(6):1596-1606. doi: 10.1093/gbe/evy116. Genome Biol Evol. 2018. PMID: 29893833 Free PMC article.
-
Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humans.Antimicrob Agents Chemother. 2014 Jul;58(7):3650-9. doi: 10.1128/AAC.02637-14. Epub 2014 Apr 14. Antimicrob Agents Chemother. 2014. PMID: 24733475 Free PMC article.
-
Progress in the application of nanoparticles for the treatment of fungal infections: A review.Mycology. 2023 Dec 8;15(1):1-16. doi: 10.1080/21501203.2023.2285764. eCollection 2024. Mycology. 2023. PMID: 38558835 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources